HK1248549A1 - Extended-release formulation for reducing the frequency of urination and method of use thereof - Google Patents
Extended-release formulation for reducing the frequency of urination and method of use thereofInfo
- Publication number
- HK1248549A1 HK1248549A1 HK18108255.3A HK18108255A HK1248549A1 HK 1248549 A1 HK1248549 A1 HK 1248549A1 HK 18108255 A HK18108255 A HK 18108255A HK 1248549 A1 HK1248549 A1 HK 1248549A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- urination
- extended
- frequency
- reducing
- release formulation
- Prior art date
Links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/343,332 US20120135050A1 (en) | 2010-07-08 | 2012-01-04 | Extended-release formulation for reducing the frequency of urination and method of use thereof |
US13/343,349 US20120141554A1 (en) | 2010-07-08 | 2012-01-04 | Delayed release formulation for reducing the frequency of urination and method of use thereof |
EP12150403.9A EP2612660B1 (en) | 2012-01-04 | 2012-01-06 | Extended-release formulation for reducing the frequency of urination and method of use thereof |
US13/424,000 US8236857B2 (en) | 2010-07-08 | 2012-03-19 | Extended-release formulation for reducing the frequency of urination and method of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1248549A1 true HK1248549A1 (en) | 2018-10-19 |
Family
ID=48714360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18108255.3A HK1248549A1 (en) | 2012-01-04 | 2014-01-08 | Extended-release formulation for reducing the frequency of urination and method of use thereof |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN107569690A (en) |
HK (1) | HK1248549A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2923438T3 (en) * | 2014-11-20 | 2022-09-27 | Serenity Pharmaceuticals Llc | Compositions comprising low doses of desmopressin in combination with an alpha-adrenergic receptor antagonist |
SG11201805527QA (en) * | 2015-09-30 | 2018-07-30 | Wellesley Pharmaceuticals Llc | Composition for reducing the frequency of urination, method of making and use thereof |
CN107224428A (en) * | 2017-05-22 | 2017-10-03 | 湖南金健药业有限责任公司 | Parenteral solution containing naproxen sodium and preparation method thereof |
CN113939277B (en) * | 2019-04-30 | 2024-04-09 | 特瑞纲制药有限公司 | Formulations and methods for drug infusion into the bladder and treatment of bladder diseases |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4775535A (en) * | 1986-04-04 | 1988-10-04 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
EA002806B1 (en) * | 1997-09-11 | 2002-10-31 | Нюкомед Данмарк А/С | Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaid) |
CN1436532A (en) * | 2002-02-06 | 2003-08-20 | 檀德宏 | Medicine for treating benign prostate hyperplasia |
PL372395A1 (en) * | 2002-02-19 | 2005-07-25 | Pharmacia Corporation | Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
CN101648017A (en) * | 2008-08-12 | 2010-02-17 | 许洁 | United medicinal composition used for treating urogenital system and lower urinary tract diseases |
-
2012
- 2012-05-21 CN CN201710799446.9A patent/CN107569690A/en active Pending
- 2012-05-21 CN CN2012101593429A patent/CN103191429A/en active Pending
-
2014
- 2014-01-08 HK HK18108255.3A patent/HK1248549A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN103191429A (en) | 2013-07-10 |
CN107569690A (en) | 2018-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL274404A (en) | Expandable body device and method of use | |
IL261768B (en) | Devices and methods for the treatment of tissue | |
HK1243921A1 (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
IL232715A0 (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
HK1200690A1 (en) | Expandable body device and method of use | |
ZA201403762B (en) | Delayed-release formulation for reducing the frequency of urination and method of use thereof | |
RS59200B1 (en) | C4-monomethyl triterpenoid derivatives and methods of use thereof | |
EP2709562A4 (en) | Tissue restraining devices and methods of use | |
EP2613735A4 (en) | Devices and methods for the treatment of vascular defects | |
EP2825242A4 (en) | Devices and methods for the treatment of vascular defects | |
EP2790709A4 (en) | Hemostatic agents and methods of use | |
EP2938289A4 (en) | Devices and methods for the treatment of vascular defects | |
ZA201408055B (en) | Compositions and methods for the treatment of local pain | |
IL261232A (en) | Pharmaceutical formulation for reducing frequency of urination and method of use thereof | |
HK1249438A1 (en) | Delayed release formulation for reducing the frequency of urination and method of use thereof | |
HK1203395A1 (en) | Implantable devices and methods for the evaluation of active agent | |
HK1248549A1 (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
HK1203159A1 (en) | Prophylactic agent and or therapeutic agent for stress urinary incontinence | |
AP3759A (en) | Method for preparing phenyloxymethyl-nitro-imidazole derivatives and use of the same |